JenniferHutchinsonPharmD, BCOP(She/Her)

PubMed

• 38 citations
  Sacituzumab Govitecan For Metastatic Triple Negative Breast Cancer: Clinical Overview And Management Of Potential Toxicities.
  Laura Spring, Erika Nakajima, Jennifer Hutchinson, Elene Viscosi, Gayle C. Blouin
  The Oncologist. 2021-10-01
• 3 citations
  Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
  Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Jennifer A Hutchinson, Lindsey Mortensen
  Therapeutic Advances in Medical Oncology. 2022-01-01
• 1 citations
  Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.
  Shannon McLaughlin, Erika Nakajima, Yael Bar, Jennifer A Hutchinson, Jennifer Shin
  Therapeutic Advances in Medical Oncology. 2023-01-01

Journal Articles

• Palbociclib-induced hepatotoxicity in a patient with breast cancer: A case report.  
  Hutchinson JA, Green J, Kim JH, Jacques C, Haggett D, Straw O, Shin J., J Hem Oncol Pharm, 4/2023
• New treatments for early stage and metastatic breast cancer  
  Hutchinson JA, Oncolytics Today, 10/2020

Abstracts/Posters

• Real-world outcomes of KEYNOTE-522
  6. Rechenberg K, Ronayne K, Kim EB, Hutchinson JA, Hematology/Oncology Pharmacist Association Meeting, Phoenix, AZ, 4/2023
• Incidence of alpelisib-induced hyperglycemia at a large academic medical center
  Malespini J, Yu L, Kim EB, Hutchinson J, Hematology/Oncology Pharmacist Association Meeting, 3/2022
• Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors
  Denault E, Nakajima E, Naranbhai V, Balazs A, Mortsensen L, Niehoff E, Barabell C, Hutchinson J, Wander S, Rosenstock A, Ellisen L, Moy B, Isakoff S, Gainor J, Iafrate..., 2021 San Antonio Breast Cancer Symposium, 12/2021
• Incidence of alpelisib-induced hyperglycemia at a large academic medical center
  Malespini J, Yu L, Kim EB, Hutchinson J, Vizient University Health System Consortium Pharmacy Network Meeting, 12/2021
• Patients with steroid-refractory toxicity following immune checkpoint inhibitors: Frequent hospitalizations and long duration of illness
  Bothwell M, Cheng A, Zubiri L, Mooradian M, Semenov Y, Blouin G, Hutchinson J, Tavares E, Rostamnjad L, Jackson M, Reynolds K, Journal of Clinical Oncology, 5/2021
• Adjuvant zoledronic acid in early-stage breast cancer
  Uchida E, Hutchinson J, Blouin G, Hematology/Oncology Pharmacist Association Meeting, 4/2021
• Creating an online education tool for use in virtual chemotherapy teaches for breast cancer
  Straw O, Hutchinson J, Haggett D, Winters L, Brennan N, Darling A, 46th Annual Oncology Nursing Society Congress, 4/2021
• Adjuvant zoledronic acid in early-stage breast cancer
  Uchida E, Hutchinson J, Blouin G, Vizient University Health System Consortium Pharmacy Network Meeting, 12/2020
• Denosumab use for cancer in frail older adults: A national study
  JA Hutchinson, AR Zullo, CM Berard-Collins, JP Huynh, Hematology/Oncology Pharmacists Association, Fort Worth, TX, 4/2019
• Denosumab use for cancer in frail older adults: A national study
  JA Hutchinson, AR Zullo, CM Berard-Collins, JP Huynh, American Society of Health-system Pharmacists, Anaheim, CA, 12/2018
• Effect of beta blockers on progression of heart failure in patients diagnosed with acute myelogenous leukemia undergoing induction treatment with mitoxantrone
  JA Hutchinson, J Bednarik, American Society of Health-system Pharmacists, Orlando, FL, 12/2017
• Join now to see all

Lectures

• Cytotoxic Chemotherapy Overview 
  Massachusetts General Hospital - 10/2023
• Pharmacy and Therapeutics Committees 
  MCPHS University - 3/2023
• Treatment of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer 
  Massachusetts General Hospital, Boston, MA - 1/2022
• Clinical Considerations of Herbal Supplements in Cancer Care 
  Massachusetts General Hospital, Boston, MA - 12/2021
• Updates in Investigational Trial Design 
  Rhode Island Hospital, Providence, RI - 4/2019
• Cardiotoxicity Management in Oncology 
  University of Rhode Island College of Pharmacy - Kingston, RI - 3/2019
• Effect of beta blockers on progression of heart failure in patients diagnosed with acute myelogenous leukemia undergoing induction treatment with mitoxantrone 
  Eastern States Conference - Hershey, PA - 4/2018
• Join now to see all